FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Guidance on Necessity of IND

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance: Investigational New Drug Applications (INDs) Determining Whether Human Research...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Bio Focus, Dako Denmark, Deroyal Cientifica De Latinoamerica, Graftys, Irenda, S...

FDA Revises GDUFA Guidance

[ Price : $8.95]

FDA adds questions and answers to its guidance on GDUFA implementation.

Drug Failures Vary by Study Phase, Drug Class: Study

[ Price : $8.95]

A Tufts Center for the Study of Drug Development Impact Report says causes of drug failures in clinical trial vary according to tr...

FDA Rejects Requested Opioid Changes

[ Price : $8.95]

FDA rejects several requests from Physicians for Responsible Opioid Prescribing for changes to opioid labeling.

Comments Sought on Device Fellowship Program

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on the value of CDRHs application form for participation in the Medical Device Fellows...

BE Guidance on Advair Generics

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance: entitled Bioequivalence Recommendations for Fluticasone Propionate; Salmet...

Change Control is FDA Focus in Quality Agreements: Attorney

[ Price : $8.95]

A food and drug lawyer says NDA sponsors who use contract manufacturing organizations should define change control in their qualit...

Biodel Claims Product Comparability to Lillys Humalog

[ Price : $8.95]

Biodel reports positive Phase 2 clinical trial data for BIOD-123, an investigational ultra-rapid-acting mealtime insulin being eva...

McNeil Recalls 3 Lots of Motrin Infant Drops

[ Price : $8.95]

McNeil Consumer Healthcare recalls three lots of concentrated Motrin Infants Drops Original Berry Flavor 1/2 fl oz bottles after p...